Amicus Therapeutics, Inc.FOLDNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-1.31%
↑ 86% above average
Average (9y)
-9.05%
Historical baseline
Range
High:-1.31%
Low:-23.43%
CAGR
-20.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -1.31% | +28.5% |
| 2023 | -1.83% | +62.1% |
| 2022 | -4.83% | +26.7% |
| 2021 | -6.58% | -66.4% |
| 2020 | -3.96% | +65.7% |
| 2019 | -11.55% | +32.9% |
| 2018 | -17.21% | -72.6% |
| 2017 | -9.97% | +57.4% |
| 2016 | -23.43% | -138.0% |
| 2015 | -9.84% | - |